ArticleJournal of the American Chemical Society2023

The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition.

Timm O Koller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.